Skip to content ↓

Fighting a giant foe at a tiny scale

Professor Paula Hammond uses nanoscale biomaterials to craft anti-cancer treatments tiny enough to get through the bloodstream and enter tumors.
Press Inquiries

Press Contact:

Nancy DuVergne Smith
Phone: 617-253-8217
MIT Alumni Association
Close
MIT Professor Paula Hammond
Caption:
MIT Professor Paula Hammond
Credits:
Photo courtesy of MIT Alumni Association

Paula Hammond’s research focuses on using nanoscale biomaterials to attack cancer, which she calls “a supervillain with incredible superpowers.” Using targeted nanoparticles, she is attempting to turn off the natural defenses of mutant genes and deliver a deadly punch to the cancer cell. Her work will soon be translated into clinical practice through partnerships with pharmaceutical companies, entrepreneurial partners, and startups in health care.

Long interested in reading and the arts, Hammond ’84, PhD ’93 considered writing children’s novels before she decided to study chemical engineering as an undergraduate at MIT. After working at Motorola for two years, she earned her master’s degree at Georgia Tech and then returned to MIT for a new PhD program in polymer science. In 1995 Hammond joined the MIT faculty, where she is now the David H. Koch Professor of Engineering and head of the Department of Chemical Engineering.

During her 2003 sabbatical, she began to focus on biomaterials. As someone entering that field in mid-career, she says, “I brought a new perspective, with a materials design approach.”

Since then, she has merged design and polymer engineering to create breakthroughs in drug delivery technology. By layering negatively and positively charged molecules, Hammond and her team can create coated meshes and wound dressings that gradually release combinations of an antibiotic and a growth factor to help the wound heal, support bone regeneration, or control the scarring that can result from a burn or tissue injury.

This same layering concept is used to treat cancer, says Hammond. By taking a nanoparticle core loaded with drugs that kill cancer cells, surrounding that core with layers that contain silencing RNA to turn off the genes that promote cancer survival, and adding a final outer layer that helps the nanoparticle reach the tumor, it is possible to target drug-resistant cancer cells.

During her 2015 presentation for the live show "TED Talks: Science and Wonder," Hammond said that, using molecular engineering, “we can actually design a superweapon that can travel through the bloodstream. It has to be tiny enough to get through the bloodstream, it has got to be small enough to penetrate the tumor tissue, and it’s got to be tiny enough to be taken up inside the cancer cell. To do this job well, it has to be about one one-thousandth the size of a human hair.”

Hammond was elected to the National Academy of Engineering in 2017 and the National Academy of Medicine in 2016. She is also a member of the American Academy of Arts and Sciences

This story originally appeared in the September/October 2017 issue of MIT Technology Review magazine.

Press Mentions

C&EN

In an article for C&EN, Marsha-Ann Watson explores what inspired Prof. Paula Hammond, head of MIT’s Department of Chemical Engineering, to pursue a career in engineering, how her research at MIT has evolved to focus on biomedical applications and the importance of inclusivity and diversity. Hammond recalls how her first female science teacher inspired her love of chemistry: “I learned that I loved chemistry and that I could actually use that interest to perhaps create things,” she explains.

Related Links

Related Topics

Related Articles

More MIT News